A Prospective Multicenter Single-Arm Staged Study to Evaluate the Safety and Effectiveness of Embrace Hydrogel Embolic For Transcatheter Embolization of Arterial Bleeding in Solid Organs and Peripheral Arteries

The purpose of this study is to evaluate the safety and effectiveness of a new embolization device, the Embrace Hydrogel Embolic System (HES). This embolic device is a combination of liquids injected into the blood vessel(s). The liquids combine to form a soft plug that close the vessel(s) to stop the bleeding. Embrace HES has not been approved by the U.S. Food and Drug Administration (FDA). It is available only to doctors participating in this research study.